Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 13.50% vs 16.51% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 29.60% vs 31.39% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 24.79% vs 18.91% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 45.16% vs -40.38% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of RPG LifeScience. With
Figures in Rs cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
582.05
8,558.51
-7,976.46
-93.20%
Other Operating Income
0.00
0.00
0.00
Total Operating income
582.05
8,558.51
-7,976.46
-93.20%
Raw Material Cost
120.65
859.11
-738.46
-85.96%
Purchase of Finished goods
61.18
1,825.86
-1,764.68
-96.65%
(Increase) / Decrease In Stocks
2.70
-60.74
63.44
104.45%
Employee Cost
132.15
1,890.84
-1,758.69
-93.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
137.22
1,859.00
-1,721.78
-92.62%
Total Expenditure (Excl Depreciation)
453.90
6,374.07
-5,920.17
-92.88%
Operating Profit (PBDIT) excl Other Income
128.15
2,184.44
-2,056.29
-94.13%
Other Income
7.21
266.64
-259.43
-97.30%
Operating Profit (PBDIT)
135.36
2,451.08
-2,315.72
-94.48%
Interest
0.45
14.57
-14.12
-96.91%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
134.91
2,436.51
-2,301.60
-94.46%
Depreciation
17.07
317.46
-300.39
-94.62%
Profit Before Tax
117.84
2,119.05
-2,001.21
-94.44%
Tax
30.18
399.17
-368.99
-92.44%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
87.66
1,719.88
-1,632.22
-94.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
87.66
1,823.41
-1,735.75
-95.19%
Equity Capital
13.23
40.06
-26.83
-66.97%
Face Value
8.00
1.00
0.00
Reserves
361.62
9,583.75
-9,222.13
-96.23%
Earnings per share (EPS)
53.01
45.52
7.49
16.45%
Diluted Earnings per share
53.01
45.45
7.56
16.63%
Operating Profit Margin (Excl OI)
22.02%
25.52%
0.00
-3.50%
Gross Profit Margin
23.18%
28.47%
0.00
-5.29%
PAT Margin
15.06%
20.10%
0.00
-5.04%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 582.05 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 13.50% vs 16.51% in Mar 2023
Annual - Standalone Net Profit
Standalone Net Profit 87.66 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 29.60% vs 31.39% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 128.15 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 24.79% vs 18.91% in Mar 2023
Annual - Interest
Interest 0.45 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 45.16% vs -40.38% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.02%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023